Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
Recruiting
Observational Study
Sepsis
Septic Shock
Sepsis, Severe
Infections
Infection Viral
Infection, Bacterial
Infections, Respiratory
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 3,300 (estimated)
- Sponsor
- Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC) · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Objectives:
1. To compare the immune response of patients with or without sepsis presenting to the ED with a(n) (suspected) infection.
2. To determine immune response aberrations that are associated with an increased risk of developing sepsis in patients presenting to the ED with a(n) (suspected) infection without sepsis.
3. To determine the long term cognitive and physical sequelae of sepsis aft…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 18 years or higher
* Presentation at the Emergency Department (ED)
* Clinical suspicion of infection or earlier confirmed infection
* Modified Early Warning Score (MEWS) of 2 or higher
Exclusion Criteria:
* No informed consent given
Contacts